Suleyman Yalcin Seh. Hast.

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Gastric and oesophageal cancer

Running trials

• Active, not recruiting

  Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

  NCT04704934· Phase 3· Daiichi Sankyo· Source